LOGIN
Cell Therapy With Autologous Bone Marrow Cells for Plate-Stabilized Proximal Humerus Fractures
June 2025
Cell Therapy With Autologous Bone Marrow Cells for Plate-Stabilized Proximal Humerus Fractures
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Cell-Based Therapy by Autologous Bone Marrow-Derived Mononuclear Cells for Bone Augmentation of Plate-Stabilized Proximal Humeral Fractures: A Multicentric, Randomized, Open Phase IIa study.
Stem Cells Transl Med . 2024 Jan 12;13(1):3-13.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Ninety four patients with proximal humerus fractures were randomized to receive either autologous bone marrow-derived mononuclear cells (BMC) on a β-tricalcium phosphate (β-TCP) scaffold (n=47) or β-TCP scaffold alone (n=47) during surgical fixation with an angular stable plate. Outcomes were evaluated over 12 weeks. The study assessed radiographic healing and functional shoulder recovery (DASH sc...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.